The biomarkers included loss of tumor suppressor p53 expression associated with p53 mutations, that are the most often encountered mutations in HNSCC associated with metastatic behavior and radio resistance [11]. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.